본문 바로가기
KERD
논문KCI 등재

인후두 역류 질환: 진단 및 치료

Laryngopharyngeal Reflux Disease: Diagnosis and Treatment in 2021

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Laryngopharyngeal reflux disease (LPRD) is an inflammatory condition of the upper aerodigestive tract mucosa induced by reflux content from stomach. Some of vocal cord diseases are associated with laryngopharyngeal reflux. Because of the pathophysiological features, proton pump inhibitor shows therapeutic effect on some vocal cord diseases. As like that, the gastric reflux contents can make macroscopic or microscopic morphological changes in the upper aerodigestive tract mucosa. Although the pathophysiology of LPRD is relatively clear, clinical diagnosis is still difficult. The diagnosis of LPRD includes objective tests such as 24-hours multichannel intraluminal impedance-pH metry and subjective tests such as questionnaire method. However, the objective verification of reflux is difficult due to invasiveness of the method, and the questionnaire methods have limitations because many symptoms are not specific for LPRD. Moreover, most methods are not fully standardized until now. Despite these limitations, many researchers are struggling to standardize diagnosis and treatment of LPRD, and there are several new achievements recently. Therefore, the purpose of this article is to review the recent literature on the clinical presentation, diagnosis, and treatment of LPRD, and to systematize our knowledge.

Abstract

Laryngopharyngeal reflux disease (LPRD) is an inflammatory condition of the upper aerodigestive tract mucosa induced by reflux content from stomach. Some of vocal cord diseases are associated with laryngopharyngeal reflux. Because of the pathophysiological features, proton pump inhibitor shows therapeutic effect on some vocal cord diseases. As like that, the gastric reflux contents can make macroscopic or microscopic morphological changes in the upper aerodigestive tract mucosa. Although the pathophysiology of LPRD is relatively clear, clinical diagnosis is still difficult. The diagnosis of LPRD includes objective tests such as 24-hours multichannel intraluminal impedance-pH metry and subjective tests such as questionnaire method. However, the objective verification of reflux is difficult due to invasiveness of the method, and the questionnaire methods have limitations because many symptoms are not specific for LPRD. Moreover, most methods are not fully standardized until now. Despite these limitations, many researchers are struggling to standardize diagnosis and treatment of LPRD, and there are several new achievements recently. Therefore, the purpose of this article is to review the recent literature on the clinical presentation, diagnosis, and treatment of LPRD, and to systematize our knowledge.

참고문헌 (74)

  1. Lechien JR, "Clinical outcomes of laryngopharyngeal reflux treatment : A systematic review and meta-analysis", Laryngoscope, 129(5), pp.1174~1187 (2019)
  2. Koufman JA, "Laryngopharyngeal reflux : Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery", Otolaryngol Head Neck Surg, 127(1), pp.32~35 (2002)
  3. Johnston N, "Airway reflux", Ann N Y Acad Sci, 1381(1), pp.5~13 (2016)
  4. Sereg-Bahar M, "Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux-a prospective comparative study", Clin Otolaryngol, 40(3), pp.234~239 (2015)
  5. Amarasiri DL, "Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma : A laboratory study", BMC Pulm Med, 13, pp.33~ (2013)
  6. Lechien JR, "Laryngopharyngeal reflux disease : Clinical presentation, diagnosis and therapeutic challenges in 2018", Curr Opin Otolaryngol Head Neck Surg, 26(6), pp.392~402 (2018)
  7. Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease(GERD) : A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury", Laryngoscope, 101(S53), pp.1~78 (1991)
  8. Chen XM, "Prevalence of laryngopharyngeal reflux disease in Fuzhou region of China", Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 51(12), pp.909~913 (2016)
  9. Spantideas N, "Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors", BMC Ear Nose Throat Disord, 15, pp.7~ (2015)
  10. Koufman JA, "Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders", Otolaryngol Head Neck Surg, 123(4), pp.385~388 (2000)
  11. Lechien JR, "Change of signs, symptoms and voice quality evaluations throughout a 3-to 6-month empirical treatment for laryngopharyngeal reflux disease", Clin Otolaryngol, 43(5), pp.1273~1282 (2018)
  12. Lee YS, "Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease", Eur Arch Otorhinolaryngol, 268(6), pp.863~869 (2011)
  13. Habermann W, "Reflux symptom index and reflux finding score in otolaryngologic practice", J Voice, 26(3), pp.e123~e127 (2012)
  14. Jaspersen D, "Prevalence of extra-oesophageal manifestations in gastrooesophageal reflux disease : An analysis based on the ProGERD Study", Aliment Pharmacol Ther, 17(12), pp.1515~1520 (2003)
  15. Dore MP, "Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease", Dig Dis Sci, 52(2), pp.463~468 (2007)
  16. Fuchs HF, "Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux disease", Dis Esophagus, 31(10), pp.1~8 (2018)
  17. Drinnan M, "Gastroesophageal and extraesophageal reflux symptoms : similarities and differences", Laryngoscope, 125(2), pp.424~430 (2015)
  18. Nason KS, "A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms", J Clin Gastroenterol, 47(9), pp.762~768 (2013)
  19. Mosli M, "Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire", Saudi J Gastroenterol, 24(4), pp.236~241 (2018)
  20. Chen M, "Reflux symptom index and reflux finding score in 91 asymptomatic volunteers", Acta Otolaryngol, 138(7), pp.659~663 (2018)
  21. Gao CK, "Different cutoffs of the reflux finding score for diagnosing laryngopharyngeal reflux disease should be used for different genders", Acta Otolaryngol, 138(9), pp.848~854 (2018)
  22. Mendelsohn AH, "The effects of reflux on the elderly : The problems with medications and interventions", Otolaryngol Clin North Am, 51(4), pp.779~787 (2018)
  23. Lechien JR, "Impact of age on laryngopharyngeal reflux disease presentation : A multi-center prospective study", Eur Arch Otorhinolaryngol, 274(10), pp.3687~3696 (2017)
  24. Hicks DM, "The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers", J Voice, 16(4), pp.564~579 (2002)
  25. Chang BA, "The reliability of the reflux finding score among general otolaryngologists", J Voice, 29(5), pp.572~577 (2015)
  26. Musser J, "A comparison of rating scales used in the diagnosis of extraesophageal reflux", J Voice, 25(3), pp.293~300 (2011)
  27. Lechien JR, "Instruments evaluating the clinical findings of laryngopharyngeal reflux : A systematic review", Laryngoscope, 129(3), pp.720~736 (2019)
  28. Lechien JR, "Laryngopharyngeal reflux and voice disorders : A multifactorial model of etiology and pathophysiology", J Voice, 31(6), pp.733~752 (2017)
  29. Wood JM, "Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?", Clin Otolaryngol, 43(1), pp.158~163 (2018)
  30. Ali Mel-S, "Mucin gene expression in reflux laryngeal mucosa : Histological and in situ hybridization observations", Int J Otolaryngol, 2014, pp.264075~ (2014)
  31. Hanson DG, "Quantitative color analysis of laryngeal erythema in chronic posterior laryngitis", J Voice, 12(1), pp.78~83 (1998)
  32. Arruda Henry MA, "Gastroesophageal reflux disease and vocal disturbances", Arq Gastroenterol, 48(2), pp.98~103 (2011)
  33. Jin BJ, "Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients", Laryngoscope, 118(5), pp.938~941 (2008)
  34. Ramírez DAM, "Acoustic analysis of voice and electroglottography in patients with laryngopharyn-geal reflux", J Voice, 32(3), pp.281~284 (2018)
  35. Doo JG, "Changes in pharyngeal baseline impedance in patients with laryngopharyngeal reflux", Otolaryngol Head Neck Surg, 163(3), pp.563~568 (2020)
  36. Belafsky PC, "Validity and reliability of the reflux symptom index(RSI)", J Voice, 16(2), pp.274~277 (2002)
  37. Carrau RL, "Validation of a quality-of-life instrument for laryngopharyngeal reflux", Arch Otolaryngol Head Neck Surg, 131(4), pp.315~320 (2005)
  38. Lechien JR, "The development of new clinical instruments in laryngopharyngeal reflux disease : The international project of young otolaryngologists of the International Federation of Oto-rhino-laryngological Societies", Eur Ann Otorhinolaryngol Head Neck Dis, 135(5S), pp.S85~S91 (2018)
  39. Lechien JR, "Validity and reliability of the reflux symptom score", Laryngoscope, 130(3), pp.E98~E107 (2020)
  40. Galli J, "Biliary laryngopharyngeal reflux : A new pathological entity", Curr Opin Otolaryngol Head Neck Surg, 14(3), pp.128~132 (2006)
  41. 이준석, "Comparison of Characteristics According to Reflux Type in Patients With Laryngopharyngeal Reflux", Clinical and Experimental Otorhinolaryngology, 11(2), pp.141~154 (2018), 대한이비인후과학회[DOI]
  42. Kim SI, "Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux", Clin Otolaryngol, 42(3), pp.584~591 (2017)
  43. Hoppo T, "How much pharyngeal exposure is"normal"? Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance(HMII)", J Gastrointest Surg, 16(1), pp.16~24 (2012)[DOI]
  44. Maldonado A, "Laryngopharyngeal reflux identified using a new catheter design : Defining normal values and excluding artifacts", Laryngoscope, 113, pp.349~355 (2003)
  45. Jacob P, "Proximal esophageal pH-metry in patients with ‘reflux laryngitis’", Gastroenterology, 100(2), pp.305~310 (1991)
  46. Eubanks TR, "Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux", J Gastrointest Surg, 5(2), pp.183~190 (2001)[DOI]
  47. Gupta R, "Laryngopharyngeal reflux : Current concepts and questions", Curr Opin Otolaryngol Head Neck Surg, 17(3), pp.143~148 (2009)
  48. Chander B, "24 versus 48-hour bravo pH monitoring", J Clin Gastroenterol, 46(3), pp.197~200 (2012)
  49. Ford CN, "Evaluation and management of laryngopharyngeal reflux", JAMA, 294(12), pp.1534~1540 (2005)
  50. Gupta N, "Evaluation of a laryngopharyngeal reflux management protocol", Am J Otolaryngol, 37(3), pp.245~250 (2016)
  51. Gyawali CP, "Modern diagnosis of GERD : The Lyon Consensus", Gut, 67(7), pp.1351~1362 (2018)
  52. Lien HC, "Responder definition of a patient-reported outcome instrument for laryngopharyngeal reflux based on the US FDA guidance", Value Health, 18(4), pp.396~403 (2015)
  53. Masaany M, "Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux", J Laryngol Otol, 125(5), pp.502~508 (2011)
  54. Lechien JR, "Impact of laryngopharyngeal reflux on subjective and objective voice assessments : A prospective study", J Otolaryngol Head Neck Surg, 45(1), pp.59~ (2016)
  55. Piper DW, "pH stability and activity curves of pepsin with special reference to their clinical importance", Gut, 6(5), pp.506~508 (1965)
  56. Jung AR, "Association between pepsin in the saliva and the subjective symptoms in patients with laryngopharyngeal reflux", J Voice, 33(2), pp.150~154 (2019)
  57. Wang J, "Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux : A meta-analysis", Eur Arch Otorhinolaryngol, 275(3), pp.671~678 (2018)
  58. Wassenaar E, "Pepsin detection in patients with laryngopharyngeal reflux before and after fundoplication", Surg Endosc, 25, pp.3870~3876 (2011)
  59. Saritas Yuksel E, "Rapid salivary pepsin test : Blinded assessment of test performance in gastroesophageal reflux disease", Laryngoscope, 122(6), pp.1312~1316 (2012)
  60. Klimara MJ, "Correlation of salivary and nasal lavage pepsin with MII-pH testing", Laryngoscope, 130(4), pp.961~966 (2020)
  61. Na SY, "Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux", Laryngoscope, 126(12), pp.2770~2773 (2016)
  62. Weitzendorfer M, "Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux", Laryngoscope, 130(7), pp.1780~1786 (2020)
  63. Fortunato JE, "Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance", pH monitoring in pediatric patients, 2017, pp.29(2), e12936~
  64. Lee YC, "Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease : A prospective multicenter study", JAMA Otolaryngol Head Neck Surg, 139(12), pp.1291~1295 (2013)
  65. Kroch DA, "Medical treatment of gastroesophageal reflux disease", World J Surg, 41(7), pp.1678~1684 (2017)
  66. Zalvan CH, "A comparison of alkaline water and Mediterranean diet vs proton pump inhibition for treatment of laryngopharyngeal reflux", JAMA Otolaryngol Head Neck Surg, 143(10), pp.1023~1029 (2017)
  67. Koufman JA, "Low-acid diet for recalcitrant laryngopharyngeal reflux : Therapeutic benefits and their implications", Ann Otol Rhinol Laryngol, 120(5), pp.281~287 (2011)
  68. Lechien JR, "Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease : Our experience on 65 patients", Clin Otolaryngol, 44(3), pp.379~384 (2019)
  69. Yang J, "Treating laryngopharyngeal reflux : Evaluation of an anti-reflux program with comparison to medications", Am J Otolaryngol, 39(1), pp.50~55 (2018)
  70. Pisegna JM, "A mixed-methods study of patient views on reflux symptoms and medication routines", J Voice, 31(3), pp.381.e15~381.e25 (2017)[DOI]
  71. Lee YC, "The effect of baclofen combined with a proton pump inhibitor in patients with refractory laryngopharyngeal reflux : A prospective, open-label study in thirty-two patients", Clin Otolaryngol, 44(3), pp.431~434 (2019)
  72. Mazzini Gda S, "Impact of laparoscopic fundoplication for the treatment of laryngopharyngeal reflux : Review of the literature", Int J Otolaryngol, 2012, pp.291472~ (2012)
  73. Lin RJ, "Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease", Laryngoscope, 128(1), pp.133~137 (2018)
  74. Eusebi LH, "Proton pump inhibitors : Risks of long-term use", J Gastroenterol Hepatol, 32(7), pp.1295~1302 (2017)

관련 논문AI추천

이 간행물의 다른 논문 (8건)